Rhythm Biosciences Limited (FRA:0RY)

Rhythm Biosciences Statistics

Total Valuation

FRA:0RY has a market cap or net worth of EUR 17.02 million. The enterprise value is 16.81 million.

Market Cap	17.02M
Enterprise Value	16.81M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	322.74M
Shares Outstanding	n/a
Shares Change (YoY)	+17.94%
Shares Change (QoQ)	+10.21%
Owned by Insiders (%)	13.88%
Owned by Institutions (%)	7.69%
Float	232.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.55
PB Ratio	46.19
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.86
EV / Sales	9.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.22

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.68.

Current Ratio	0.84
Quick Ratio	0.72
Debt / Equity	1.68
Debt / EBITDA	n/a
Debt / FCF	-0.38
Interest Coverage	-55.90

Financial Efficiency

Return on equity (ROE) is -501.54% and return on invested capital (ROIC) is -166.61%.

Return on Equity (ROE)	-501.54%
Return on Assets (ROA)	-107.16%
Return on Invested Capital (ROIC)	-166.61%
Return on Capital Employed (ROCE)	-554.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.47
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.71%
50-Day Moving Average	0.05
200-Day Moving Average	0.04
Relative Strength Index (RSI)	51.50
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:0RY had revenue of EUR 1.78 million and -2.14 million in losses. Loss per share was -0.01.

Revenue	1.78M
Gross Profit	1.66M
Operating Income	-2.08M
Pretax Income	-2.14M
Net Income	-2.14M
EBITDA	-1.97M
EBIT	-2.08M
Loss Per Share	-0.01

Balance Sheet

The company has 827,444 in cash and 618,135 in debt, giving a net cash position of 209,309.

Cash & Cash Equivalents	827,444
Total Debt	618,135
Net Cash	209,309
Net Cash Per Share	n/a
Equity (Book Value)	368,385
Book Value Per Share	0.00
Working Capital	-193,940

Cash Flow

In the last 12 months, operating cash flow was -1.63 million and capital expenditures -12,957, giving a free cash flow of -1.64 million.

Operating Cash Flow	-1.63M
Capital Expenditures	-12,957
Free Cash Flow	-1.64M
FCF Per Share	n/a

Margins

Gross margin is 92.95%, with operating and profit margins of -116.85% and -119.97%.

Gross Margin	92.95%
Operating Margin	-116.85%
Pretax Margin	-119.97%
Profit Margin	-119.97%
EBITDA Margin	-110.68%
EBIT Margin	-116.85%
FCF Margin	n/a

Dividends & Yields

FRA:0RY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.94%
Shareholder Yield	-17.94%
Earnings Yield	-12.56%
FCF Yield	-9.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0RY has an Altman Z-Score of -18.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.53
Piotroski F-Score	2